Imatinib related substance B(571186-93-1)
- Name: Imatinib related substance B
- Synonyms:1,4-dioxide iMatinib;iMatinib related substance B;4-[(4-Methyl-1,4-dioxido-1-piperazinyl)Methyl]-N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]phenyl]benzaMide;IMatinib (Piperidine)-N,N-dioxide;4-[4-Methyl- 1.4-dioxidepiperazin-1-yl] Methyl-N-[4 -Methyl-3-[[ 4-(pyridin-3-yl)pyriMidin-2- yl]aMino]phenyl]benzaMide
- Molecular Formula:C29H31N7O3
- Molecular Weight:525.61
- CAS Registry Number:571186-93-1
- EINECS:
- Melting Point:
- Water Solubility:
China (Mainland)] 
Assessed
Assessed
Premium
Premium
Premium
Premium
Other Product
- 1258327-07-9/(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide
- 1258327-06-8/(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis([1,1'-biphenyl]-4-yl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide
- 1258327-05-7/(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-chlorophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide
- 1258327-04-6/(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide
- 1258276-28-6/(11aS)-3,7-Bis[2,4,6-tris(1-methylethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide
- 1415235-63-0/Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 2-amino-2-methyl-N-[(1R)-2-[(4S,5R)-2-methyl-1-oxo-4-phenyl-2,7-diazaspiro[4.5]dec-7-yl]-2-oxo-1-[(phenylmethoxy)methyl]ethyl]propanamide (1:?)
- 1381992-68-2/1H-Indole-4-carboxamide, N,N'-[1,2-ethanediylbis(oxy-3,1-propanediyl)]bis[1-[5-[(2S)-1-(N-methyl-L-alanyl-L-valyl)-2-pyrrolidinyl]-3-pyridinyl]-
- 1366295-86-4/β-Alanine, N-[[3-[[(2E)-2-[[(3,5-diamino-6-chloro-2-pyrazinyl)carbonyl]imino]-1,3,8-triazaspiro[4.5]dec-8-yl]carbonyl]phenyl]sulfonyl]-, 2-(dipropylamino)-2-oxoethyl ester, butanedioate (1:?)
- 1356331-63-9/7,8-Dihydro-2,3-bis(4-methylphenyl)pyrido[2,3-b]pyrazine-5(6H)-heptanoic acid
- 1354691-78-3/Pyrido[4,3-d]pyrimidine, 5,6,7,8-tetrahydro-6-(6-methoxy-5-methyl-3-pyridinyl)-4-[(3S)-3-pyrrolidinyloxy]-
- 1334546-77-8/2-Pyridinecarboxamide, 3-amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-
- 1331846-26-4/7-Cyclopentyl-N,N-dimethyl-2-[[5-[(1R,6S)-9-methyl-4-oxo-3,9-diazabicyclo[4.2.1]non-3-yl]-2-pyridinyl]amino]-7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide
- 1262856-69-8/2-Pyridinecarboxamide, N-[3-[(3R)-5-amino-3-(difluoromethyl)-3,6-dihydro-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl-
- 1261113-96-5/2-Amino-1-[2-(4-fluorophenyl)-3-[(4-fluorophenyl)amino]-5,6-dihydro-8,8-dimethylimidazo[1,2-a]pyrazin-7(8H)-yl]ethanone
- 1260006-20-9/2-Imidazolidinone, 1-(2-chloro-4-pyridinyl)-3-(4-methyl-3-pyridinyl)-
- 1149362-88-8/CETPinhibitor
- 59308-98-4/Brimonidine
- 81787-33-9/Propanebis(thioic)acid,S1,S3-bis(1,1-dimethylethyl) ester
- 1268449-00-8/1H-lmidazolium,2-[[(4S,5S)-1,3-dimiethyl-4,5-diphenyl-2-imidazolinydene]amino]-4,5-dihydro-1,3-dimethyl-4,5-diphenyl-,choride(1:1),(4S,5S)-
- 571186-93-1/Imatinib related substance B
- 938082-57-6/Imatinib related substance C
- 955117-26-7/Tetrahydropyrazolo[1,2-a]pyrazol-1(5H)-one
- 95456-60-3/(3S,4R)-Methyl (3,4- Isopropylidenedooxypyrrolidin-2-ylidene) acetate
- 952573-42-1/9H-Fluoren-9-one-D4
- 951625-86-8/[5-(1-Amino-ethyl)-4H-[1,2,4]triazol-3-yl]-acetic acidhydrochloride
- 950256-12-9/1-(4-Bromophenyl)-N-cyclopentylmethanesulfonamide
- 950235-23-1/1-(4-Bromophenyl)-N-cyclopropylmethanesulfonamide
- 950227-44-8/1-(4-Bromophenyl)-N-isopropylmethanesulfonamide
- 949885-88-5/Diethyl-2-(tetrahydrofuran-3-yl)malonate
- 946860-07-7/1-(4-(Methylthio)pyrimidin-2-yl)hydrazine